<DOC>
	<DOCNO>NCT01610063</DOCNO>
	<brief_summary>This study genotyping tool report subject respond medication could use community psychiatry practice improve medication choice depression . After DNA test , interpretive report provide subject ' physician . The hypothesis pilot study feasible use pharmacogenomic algorithm new set treat depress subjects..</brief_summary>
	<brief_title>Evaluation Antidepressant Pharmacogenomic Algorithm Outpatient Clinical Setting</brief_title>
	<detailed_description>Antidepressant medication among widely prescribe medication . However , 35 % 45 % depressed patient complete remission illness initially treat medication . Consequently , Mayo Clinic psychiatric pharmacogenomic team develop pharmacogenomic algorithm design improve effectiveness safety antidepressant medication provide guidance medication selection appropriate dosing . This algorithm incorporate new genotyping interpretative report . The pharmacogenomic algorithm base genotyping copy four informative gene . These four gene : 1 ) Cytochrome ( P450 2D6 ) gene ; 2 ) Cytochrome ( P450 2C19 ) gene ; 3 ) Serotonin Transporter gene ( SLC6A4 ) ; 4 ) Serotonin 2A receptor gene ( 5HTR2A ) . The trial take place Franciscan Skemp Healthcare System La Crosse , Wisconsin course 12 month .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<criteria>1 . Patient age 18 80 . 2 . Major depressive disorder depressive disorder otherwise specify ascertained physician mental health professional license diagnose . 3 . Patient outpatient imminent need inpatient hospitalization , discharge inpatient schedule followup Behavioral Health psychiatrist . 4 . Patient refer see psychiatrist optimum medication management . 5 . Patient 's Hamilton Depression Rating score &gt; 14 6 . Ability read , understand sign inform consent document 1 . Serious medical illness ( ascertained via initial triage screen process ) 2 . Patients diagnosis Bipolar I disorder 3 . Patients diagnosis Schizophrenia Schizoaffective disorder 4 . Patients legally unable consent enrollment study ( i.e . patient legal guardian )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Algorithm</keyword>
	<keyword>Depression</keyword>
	<keyword>Assurex</keyword>
	<keyword>GeneSight</keyword>
</DOC>